ARTICLE | Clinical News
Veregen sinecatechins regulatory update
September 16, 2013 7:00 AM UTC
Medigene said Canada approved Veregen sinecatechins to treat genital warts. Medigene said Canadian partner Triton is expected to launch the product in the country next half. The topical formulation of polyphenols extracted from green tea leaves is marketed in the U.S., Germany, Austria, Spain, Switzerland, Serbia and the Netherlands. ...